Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PParabilis Medicines, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Parabilis Medicines, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $148K. Net result −$52.46M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $148K. Running result $148K. Revenue: $148K.
  • Cost of revenue: $0. Running result $148K.
  • Gross profit: $148K. Running result $148K.
  • Research and development cost: −$39.38M. Running result −$39.23M.
  • General and administrative: −$11.66M. Running result −$50.89M.
  • Operating income: −$50.89M. Running result −$50.89M.
  • Other expense: −$1.58M. Running result −$52.46M.
  • Pre-tax loss: −$52.46M. Running result −$52.46M.
  • Income tax benefit: $0. Running result −$52.46M.
  • Net loss: −$52.46M. Running result −$52.46M.